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Neuropeptide expressioness many different neuropeptides that modulate sensory perception like the
sensation of pain. Inhibitory neurons of the dorsal horn derive from postmitotic neurons that express Pax2,
Lbx1 and Lhx1/5, and diversify during maturation. In particular, fractions of maturing inhibitory neurons
express various neuropeptides. We demonstrate here that a coordinate molecular mechanism determines
inhibitory and peptidergic fate in the developing dorsal horn. A bHLH factor complex that contains Ptf1a acts
as upstream regulator and initiates the expression of several downstream transcription factors in the future
inhibitory neurons, of which Pax2 is known to determine the neurotransmitter phenotype. We demonstrate
here that dynorphin, galanin, NPY, nociceptin and enkephalin expression depends on Ptf1a, indicating that
these neuropeptides are expressed in inhibitory neurons. Furthermore, we show that Neurod1/2/6 and Lhx1/
5, which act downstream of Ptf1a, control distinct aspects of peptidergic differentiation. In particular, the
Neurod1/2/6 factors are essential for dynorphin and galanin expression, whereas the Lhx1/5 factors are
essential for NPY expression. We conclude that a transcriptional network operates in maturing dorsal horn
neurons that coordinately determines transmitter and peptidergic fate.
© 2008 Elsevier Inc. All rights reserved.IntroductionNeurons in the dorsal horn of the spinal cord receive somatosen-
sory information from the periphery, integrate the information and
transmit it to higher brain centers (Gillespie and Walker, 2001; Julius
and Basbaum, 2001). Dorsal horn neurons display enormous mor-
phological diversity, and physiological studies demonstrate great
functional heterogeneity (Rexed, 1952; Brown and Fyffe, 1981; Morris
et al., 2004). These neurons also vary in respect to the expression of
neuropeptides that function to modulate sensory perception, and
particularly the sensation of pain (Marti et al., 1987; Otsuka and
Yanagisawa, 1990; Todd and Spike, 1993). The molecular mechanisms
that control neuropeptide expression in the dorsal horn have not been
assessed.
The majority of dorsal horn neurons are born during a late
neurogenic phase (E12–E14.5) in the dorsal spinal cord. Two distinct
neuron types, dILA and dILB, are generated during this late phase in a
salt and pepper pattern, and were ﬁrst deﬁned by the expression of
distinct transcription factors (Gross et al., 2002; Müller et al., 2002).
Subsequent work showed that dILA neurons correspond to inhibitorycbirch@mdc-berlin.de
l rights reserved.neurons and express Gad1, whereas dILB neurons correspond to
excitatory neurons and express vGlut2 (Cheng et al., 2004, 2005).
Various genes that encode transcription factors are known to
determine the fate of the inhibitory and excitatory dorsal neurons
during the late neurogenic phase. Some of these are expressed in
progenitors, like the basic helix–loop–helix (bHLH) factor Mash1 or
the homeodomain factors Gsx1/2 (Kriks et al., 2005; Mizuguchi et al.,
2006; Wildner et al., 2006), and others appear in postmitotic neurons,
like the bHLH factor Ptf1a or the homeodomain factors Lbx1, Tlx3,
Pax2 and Lhx1/Lhx5 (Gross et al., 2002; Müller et al., 2002; Cheng et
al., 2004; Glasgow et al., 2005; Pillai et al., 2007). Inhibitory neurons
are generated excessively and at the expense of excitatory neurons in
Gsx1/2 mutants (Mizuguchi et al., 2006). Ptf1a is an important
regulator of the inhibitory neuronal fate, and inhibitory neurons are
not generated in the dorsal spinal cord and hindbrain of Ptf1amutant
mice (Glasgow et al., 2005). Finally, Pax2 and Lhx1/Lhx5 are present in
postmitotic inhibitory neurons of the dorsal horn, where they control
the initiation and maintenance of Gad1 expression, respectively
(Cheng et al., 2004; Pillai et al., 2007). Inhibitory neurons diversify
further during maturation, but the molecular control of this has not
been assessed. In particular, various neuropeptides are expressed by
distinct subpopulations of dorsal horn neurons, and it is unclear how
neuropeptide expression is regulated and if neuropeptide and
neurotransmitter identity are controlled in a coordinate manner.
382 D. Bröhl et al. / Developmental Biology 322 (2008) 381–393In order to assess this, we took advantage of a mutant mouse
strain, Gsx1/2, in which supernumerary inhibitory neurons are
generated at the expense of excitatory neurons (Mizuguchi et al.,
2006; Wildner et al., 2006). Genome wide expression analyses and in
situ hybridization of control, Gsx1/2 and Ptf1a mutant mice indicated
that many neuropeptides are expressed exclusively in inhibitory or
excitatory neurons of the dorsal horn. In particular, we observed genes
encoding prepronociceptin (Pnoc), preproenkephalin (Penk1), gala-
nin, prodynorphin (Pdyn) and neuropeptide Y (NPY) to be expressed
by inhibitory neurons, whereas others (cholecystokinin, CCK; gastrin-
releasing peptide, GRP; tachykinin 1, Tac1; adenylate cyclase activat-
ing polypeptide 1, Adcyap1/PACAP) were produced by excitatory
neurons. Ptf1a acts as a key regulator in early postmitotic neurons and
is required for Pax2 and Lhx1/5 expression; Pax2 controls the
inhibitory neurotransmitter phenotype (Cheng et al., 2004; Glasgow
et al., 2005). We demonstrate here that downstream of Pax2, the
Neurod1/2/6 genes are activated, those in turn control neuropeptide
expression in a fraction of neurons of the inhibitory lineage. Ptf1a is
also essential for the expression of Lhx1/5, and we show here that
Lhx1/5 control NPY expression. Our results demonstrate that
neuropeptide and neurotransmitter identity in dorsal horn neurons
is coordinately controlled by a hierarchical mechanism.
Materials and methods
Mouse strains, RNA isolation, microarray analysis and quantitative
RT-PCR
The generation of the mutant Gsx1, Gsx2, Ptf1aCre, Pax2, Neurod1,
Neurod6Cre (NexCre allele), Lhx1ﬂox, Lhx5, and Lbx1Cre alleles has been
previously described (Torres et al., 1995; Li et al., 1996; Naya et al.,
1997; Szucsik et al., 1997; Zhao et al., 1999; Kawaguchi et al., 2002;
Kwan and Behringer, 2002; Goebbels et al., 2006; Sieber et al.,
2007). The generation of Neurod2 mutant mice will be described
elsewhere by T. Yonemasu, K.A. Nave and colleagues. In addition,
Lhx1/5 double mutants were generated. To overcome the early
embryonic lethality of the Lhx1 mutation, we used conditional
mutagenesis and generated Lbx1Cre;Lhx1ﬂox/ﬂox;Lhx5−/− mutants.
Thus, Lhx1 was speciﬁcally mutated in dorsal spinal cord neurons
that express Lbx1.
The dorsal spinal cord was dissected from wild type and Gsx1/2
mutant mice at E12.5, E14.5 and E18.5. Tissue was collected in
RNAlater (Ambion, Austin, TX), homogenized in Trizol (Invitrogen,
Carlsbad, CA) and total RNA was isolated according to the manufac-
turer's protocol. Tissue from at least ﬁve embryos was pooled for one
sample. RNA was further puriﬁed using RNeasy MinElute Cleanup kit
(Qiagen, Hilden, Germany). cDNA synthesis and in vitro generation
and labeling of cRNA were performed according to the recommenda-
tions provided by Affymetrix (Santa Clara, CA). Ampliﬁed cRNA was
puriﬁed using the GeneChip Sample Cleanup Module (Affymetrix),
and the quality of the ampliﬁcation was veriﬁed by gel electrophor-
esis. cRNAs were fragmented and then hybridized to Affymetrix
Mouse Genome 430 2.0 arrays, using three samples per embryonic
stage and genotype. Further data processing and identiﬁcation of
differentially expressed genes were carried out in the R environment
for statistical computing (R Development Core Team 2005) using the
Bioconductor base installation (Gentleman et al., 2004) and packages
affyPLM, gcrma, and limma. Brieﬂy, array quality was assessed with
affyPLM, and data were normalized with gcrma. Probe sets with low
variance of expression across all arrays were ﬁltered out, and
differentially expressed genes were identiﬁed using the empirical
Bayes-moderated t-test implemented in the limma package. P-values
associated with the t-statistics were adjusted using a false-discovery-
rate approach to compensate for multiple testing. Genes were
considered differentially expressed if the difference of their expres-
sion level had a p-value of ≤0.05.We particularly concentrated on the analysis of neuropeptides
expressed in the dorsal horn. Microarray data indicated that all
neuropeptides detected by Affymetrix microarray experiments in the
dorsal spinal cord were differentially expressed; galanin was pre-
viously reported to be expressed in the dorsal horn, but our Affymetrix
microarray data indicated that the gene was not signiﬁcantly
expressed. Subsequent in situ hybridization provided divergent
results. Therefore, galanin expression was also analyzed by quantita-
tive RT-PCR. cDNA that had been used for microarray experiments was
diluted and qPCR was performed with the Absolute SYBR Green
Flourescein kit (Thermo Fisher Scientiﬁc, Epsom, UK). Relative
transcript abundance was determined after normalization to beta-
actin transcript levels. Relative galanin expression levels obtained
were: E12.5: 1 (control) and 2.2 (Gsx1/2 mutant); E14.5: 1.2 (control)
and 32.3 (Gsx1/2 mutant); E18.5: 5.4 (control) and 81.6 (Gsx1/2
mutant). The following primers were used: galanin: CTCACAGGCAA-
GAGGGAGTTACAA and GGATGCCAGGCAGGCTGTC; beta-actin:
AGCAGTTGGTTGGAGCAAACATCC and ACAGAAGCAATGCTGTCACCTTCC).
Immunohistochemistry and in situ hybridization
Immunohistochemistry was performed on 12 μm cryosections of
mouse embryos as described (Müller et al., 2005). The following
antibodies were used: goat anti-Neurod1 (Santa Cruz Biotechnology,
Santa Cruz, CA), rabbit anti-Neurod2 (Sigma, St. Louis, MO), rabbit
anti-Cre (Novagen, Madison, WI), rabbit anti-Pax2 (Zymed, San
Francisco, CA), rabbit and guinea-pig anti-Tlx3 (Müller et al., 2005),
guinea-pig anti-prodynorphin (Abcam, Cambridge, UK) monoclonal
anti-Lhx1/5 (Developmental Studies Hybridoma Bank, University of
Iowa). Cyanine 2 (Cy2)- or Cy3-conjugated donkey-secondary anti-
bodies (Dianova, Hamburg, Germany) were used for the detection of
primary antibodies. Fluorescence was imaged on a Zeiss LSM 5 Pascal
confocal microscope, and images were processed in Adobe Photoshop.
For in situ hybridization, embryonic tissues were embedded into
OCT compound (Sakura Finetek, Torrance, CA) and cryosectioned as
described (Wildner et al., 2008). Hybridizations were performed with
DIG-labeled riboprobes. DNA for dynorphin, galanin, nociceptin,
enkephalin, CCK, GRP, PACAP, Gad1, Neurod2 and Neurod6 were
ampliﬁed with gene-speciﬁc sets of PCR primers and cDNA templates
prepared from E12.5, E14.5 or E18.5 mouse spinal cords. Probes for NPY
and tachykinin1 were generated by the use of EST clones (IMAGE clone
482891 and6051404, respectively). Pax2 andNeurod1 speciﬁc plasmids
were generously provided by Peter Gruss (MPI Göttingen, Germany)
and Yuko Suzuki (University of Hokkaido, Japan), respectively.
For double staining of a cytoplasmic mRNA and a nuclear or
cytoplasmic protein, in situ hybridization was performed ﬁrst,
followed by immunostaining with anti-Pax2 (Zymed, San Francisco,
CA), anti-Tlx3 or anti-prodynorphin (Abcam, Cambridge, UK) and Cy3-
conjugated secondary donkey-antibodies (Dianova, Hamburg, Ger-
many). The in situ signals were photographed under transillumination
and converted into a green or red pseudocolor (see also Cheng et al.,
2004). For quantiﬁcation of neuronal subtypes that express neuropep-
tides, sections (18 μm thickness) of the E18.5 thoracic spinal cord were
hybridized with neuropeptide speciﬁc probes. Numbers of neurons
that express the various neuropeptides were counted on bright-ﬁeld
images, using four or more sections each of two or three distinct
animals for each genotype. Only cells of the dorsal spinal cord were
counted. Standard deviation was calculated and depicted as error bar
in the quantiﬁcation graphs.
Results
Gene expression proﬁling of the dorsal horn
Microarray analysis provides a useful tool to study the global gene
expression in the nervous system (Arlotta et al., 2005; Li et al., 2006).
Fig. 1. Differentially expressed genes identiﬁed by microarray analysis. Differentially expressed genes in the dorsal horn of control and Gsx1/2 mutant mice were identiﬁed by the use of Affymetrix microarrays or quantitative RT-PCR. Up- or
downregulated genes are further grouped according to the time point of expression onset. For each group, we display an exemplary expression proﬁle. (A, B) Genes encoding neuropeptides that were expressed at higher levels in Gsx1/2mutant
than in control mice are potentially expressed in inhibitory neurons and were deﬁned as category A neuropeptides. They are further subgrouped into genes with early (A) and late (B) onset of expression. (C, D) Genes encoding neuropeptides
that were expressed at lower levels in Gsx1/2 mutant than in control mice are potentially expressed in excitatory neurons and were deﬁned as category B neuropeptides. These genes are subgrouped into genes whose expression is initiated
early (C) and late (D). (E, F) Genes encoding transcription factors that were expressed at higher levels in Gsx1/2 mutant than in control mice are grouped according to their early or late onset of expression. Error bars represent the standard
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Fig. 3. Category B neuropeptides are expressed in excitatory neurons of the dorsal horn. In situ hybridization on spinal cords of control, Ptf1a−/− and Gsx1/2−/− mice at E18.5 using
probes speciﬁc for CCK, TAC1, GRP and PACAP. CCK expressing neurons are restricted to a dorsal layer in the dorsal horn (A). TAC1 expressing neurons are scattered in the dorsal horn
(E). GRP and PACAP are both expressed in neurons that locate to a superﬁcial layer of the dorsal horn (I, M). The expression of these neuropeptides was upregulated in the dorsal spinal
cords of Ptf1amutant mice, which lack all dorsal inhibitory neurons and contain more excitatory neurons (B, F, J, N). The expression of these neuropeptides was absent in the dorsal
spinal cords of Gsx1/2 double mutant mice, which lack all dorsal excitatory neurons (C, G, K, O). Neuropeptide+ cells were counted in one side of dorsal spinal cords of control and
mutant mice. Error bars represent the standard deviation (D, H, L, P). Scale bar: 100 μm.
385D. Bröhl et al. / Developmental Biology 322 (2008) 381–393Gene expression proﬁling in the nervous system is complicated by the
co-existence of many distinct neural populations. Thus, it is
technically difﬁcult to detect genes expressed in speciﬁc neuronal
subpopulations that represent only a small fraction in the entire tissue
sample. The dorsal horn represents an anatomically well-deﬁned
structure of the nervous system that contains a complex mix of
neuronal subtypes (Caspary and Anderson, 2003; Zhuang andFig. 2. Category A neuropeptides are preferentially expressed in inhibitory neurons of the do
E18.5 using probes speciﬁc for dynorphin, galanin, nociceptin, NPY and enkephalin. In additi
expression of dynorphin, galanin and NPY is restricted to the dorsal half of the spinal cord (A,
ventral part of the spinal cord (I, Q, U). In Ptf1a−/− mice, which lack all dorsal inhibitory neuro
(B, V). The dorsal expression of galanin, nociceptin, NPY and enkephalin was very strongly re
and havemore inhibitory neurons in the dorsal horn. The expression of all category A neurope
For the quantiﬁcation of neuronal subtypes, neuropeptide+ cells were counted in each side o
standard deviation. Scale bar: 100 μm.Sockanathan, 2006). From a developmental biologists point of view,
the dorsal horn is nevertheless simple, since the majority of its
neurons derive from two early neuronal subtypes characterized by the
expression of Pax2/Lhx1/5 and Tlx1/3/Lmx1b, which mature into
inhibitory and excitatory neurons, respectively (Gross et al., 2002;
Müller et al., 2002; Cheng et al., 2004; Cheng et al., 2005). We
reasoned that the low complexity during development might allow torsal horn. In situ hybridization on spinal cords of control, Ptf1a−/− and Gsx1/2−/− mice at
on, a Gad1 speciﬁc probe was used to identify inhibitory neurons. In wildtype mice, the
E, M). Nociceptin, enkephalin and Gad1 are expressed in the dorsal horn, as well as in the
ns, the expression of dynorphin and Gad1 was completely lost in the dorsal spinal cord
duced in Ptf1a−/−mice (F, J, N, R). Gsx1/2 compound mutant mice lack excitatory neurons
ptides and of Gad1was upregulated in the dorsal horn ofGsx1/2mutants (C, G, K, O, S,W).
f dorsal spinal cords of control and mutant mice (D, H, L, P, T). Error bars represent the
Fig. 4. Co-expression of neuropeptides and of Pax2 or Tlx3 in dorsal horn neurons. (A–C) Immunohistological analysis of the E18.5 dorsal horn using antibodies directed against
dynorphin (green), Pax2 (red) and Tlx3 (red). All dorsal dynorphin+ neurons co-express Pax2, which marks GABAergic neurons (A, B); co-expression of dynorphin and Tlx3 is not
observed (C). (D–O) Double staining of nuclear Pax2 (red) and Tlx3 (red) protein and cytoplasmic mRNA (green) encoding different neuropeptides in dorsal horn neurons at E18.5.
Galanin- (D–F), nociceptin- (G–I), NPY- (J–L) and enkephalin- (M–O) positive neurons frequently co-express Pax2, but not Tlx3. (P–S) Double staining for dynorphin protein (green)
and cytoplasmic mRNA (green) encoding the indicated neuropeptides in dorsal horn neurons at E18.5. Scale bars: M 100 μm; O, S 50 μm.
386 D. Bröhl et al. / Developmental Biology 322 (2008) 381–393follow global gene expression changes associated with maturation of
inhibitory and excitatory neurons in the dorsal horn. For this, we used
Gsx1/2 compound mutant mice that produce supernumerary inhibi-
tory neurons at the expense of excitatory neurons (Mizuguchi et al.,
2006).
To determine the gene expression proﬁle of dorsal horn neurons in
control and Gsx1/2 mutant mice, mRNA from the entire dorsal spinal
cord was isolated at different developmental stages (E12.5, E14.5 and
E18.5). Global gene expression was assessed using the Affymetrix
microarray technology. To control for sample variation, we compared
data obtained with three independently generated and hybridizedprobes for each developmental stage. We deﬁned changes in gene
expression that occur during maturation of the dorsal horn in control
and Gsx1/2 mutant mice. The majority of genes were expressed with
similar developmental proﬁles in both strains, indicating that
maturing inhibitory and excitatory neurons express a large number
of common genes (not shown). To ﬁnd differentially expressed genes,
we performed pair wise comparisons between control and mutant
mice at the various developmental stages using LIMMA. Thus, we
identiﬁed a number of genes, among them those encoding the
neuropeptides dynorphin, nociceptin, NPY and enkephalin, which are
upregulated in Gsx1/2 mutant mice. In addition, quantitative PCR
Fig. 5. Transient expression of Neurod1/2/6 in the developing dorsal horn. In situ hybridization of spinal cord sections from wild type, Ptf1a, Gsx1/2 and Pax2mutant mice at E12.5,
E13.5 and E18.5. (A–F) In control mice, the expression of Neurod1 initiates around E13.5. At E18.5, few Neurod1+ neurons remain in the dorsal horn. Neurod1 expression was
downregulated in the dorsal spinal cord of Ptf1a and Pax2 mutant mice at E13.5, and upregulated in Gsx1/2 mutant mice. (F–L) In control mice, Neurod2 expression in the dorsal
spinal cord peaks around E13.5; at E18.5, Neurod2 is expressed in few, scattered neurons in the dorsal horn. The expression of Neurod2was downregulated in the dorsal spinal cord of
Ptf1a and Pax2 mutant mice at E13.5, and upregulated in Gsx1/2 mutant mice. (M–R) In control mice, Neurod6 expression in the dorsal spinal cord peaks at early stages; at E18.5,
Neurod6 is expressed in a few scattered neurons in the dorsal horn. The expression of Neurod6 was reduced in the spinal cord Ptf1a and Pax2mutant mice at E13.5, and upregulated
in Gsx1/2 mutant mice. Scale bar: 100 μm.
387D. Bröhl et al. / Developmental Biology 322 (2008) 381–393demonstrated that galanin was upregulated in Gsx1/2 mutant mice.
We refer to these as category A neuropeptides (Figs. 1A, B). Similarly,
we identiﬁed neuropeptide genes that were severely downregulated
in Gsx1/2 mutant mice to which we refer as category B. These encode
CCK, PACAP, TAC1, GRP, neurotensin, somatostatin, calcitonin and
neuropeptide FF (Figs. 1C, D).
To conﬁrm that inhibitory and excitatory neurons preferentially
express these neuropeptides, we used in situ hybridization and
analyzed the dorsal horn of wild type, Ptf1a and Gsx1/2 mutant
mouse strains (Fig. 2). Ptf1a−/− mice produce no dorsal inhibitory
neurons; at their expense, increased numbers of excitatory neurons
are generated (Glasgow et al., 2005). In contrast, compound Gsx1/2
mutantmice produce increased numbers of inhibitory neurons, but no
excitatory neurons (Mizuguchi et al., 2006). In situ hybridization with
a glutamic acid decarboxylase 1 (Gad1) speciﬁc probe was used as a
control for the presence of inhibitory neurons (Figs. 2U–W). Our
analysis demonstrated that the expression of category A neuropep-
tides and of Gad1 was severely downregulated or even absent at E18.5in the dorsal horn of Ptf1a mutant mice, but these genes were
expressed by an increased number of neurons in the dorsal horn of
Gsx1/2 mutant mice (Figs. 2A–T). This demonstrates a preferential or
even exclusive expression of dynorphin, galanin, nociceptin, NPY and
enkephalin by inhibitory neurons in the dorsal horn. In contrast,
category B neuropeptides were downregulated or absent in the dorsal
horn of Gsx1/2 mutants, and were present in increased numbers in
Ptf1a mutant mice (Figs. 3A–P). This shows a preferential or even
exclusive expression of CCK, TAC1, GRP and PACAP by excitatory
neurons. To demonstrate the expression of category A neuropeptides
in inhibitory neurons, we analyzed the co-expression of neuropep-
tides with Pax2 and Tlx3. Pax2 and Tlx3 mark developing inhibitory
and excitatory neurons of the dorsal horn, respectively (Cheng et al.,
2004). For this, Pax2 and Tlx3 were detected by the use of speciﬁc
antibodies. An antibody was also used to discern dynorphin; other
category A neuropeptides were assessed by in situ hybridization. The
majority of dynorphin+ neurons in the dorsal horn co-expressed Pax2;
co-expression with Tlx3 was not observed (Figs. 4A–C). Similarly,
Fig. 6. Co-expression of Neurod1/2/6, Lhx1/5 and Tlx3 in dorsal horn neurons. Immunohistological analysis of dorsal spinal cords of control and Neurod6Cre/+ mice at E14.5. (A)
Neurod1 (green) in postmitotic neurons is mainly co-expressed with Lhx1/5 (red); (D) Neurod1+ neurons (green) that co-express Tlx3 (red) are rare. (B) Neurod2+ neurons (green) of
the dorsal spinal cord co-express Lhx1/5; (E) Neurod2+neurons (green) do not co-express Tlx3 (red). (C) In the dorsal horn of Neurod6Cre/+ mice, anti-Cre antibodies detected Cre
expressed from the Neurod6 locus (green) predominantly in Lhx1/5+ (red) cells. (F) Only very few Cre+ (green) neurons co-expressed Tlx3 (red). Scale bar: 100 μm.
388 D. Bröhl et al. / Developmental Biology 322 (2008) 381–393galanin, nociceptin, NPYand enkephalinwere co-expressedwith Pax2,
and we observed only very rarely a Tlx3 neuron that co-expressed one
of these neuropeptides (Figs. 4D–O). We further assessed if co-
expression of neuropeptides can be observed in the dorsal spinal cord.
In particular, we tested co-expressionwith dynorphin by the use of an
anti-dynorphin antibody, which was combined with in situ hybridiza-
tion to detect galanin, nociceptin, NPY and enkephalin. This demon-
strated that galanin and nociceptin are present in some, but not all
dynorphin+ neurons (Figs. 4P, Q). In contrast, NPY and enkephalin
were not co-expressed with dynorphin (Figs. 4R, S).
To identify candidate transcription factors that control the
expression of neuropeptides in inhibitory neurons, we deﬁned
differentially expressed transcription factors in control and Gsx1/2
mutant mice. A number of factors were upregulated in the dorsal horn
of Gsx1/2 mutant mice. Expression of one group (Pax8 and the Lim
homeodomain factors Lhx1 and Lhx5) peaked at E12.5, and the
expression of a second group (the bHLH factors Neurod1, Neurod2,
Neurod6 (also known as Nex), Bhlhb5, and the homeodomain factor
Gbx1) peaked at E14.5 (Figs. 1E, F). Pax2/5/8, Lhx1/5 and Gbx1 are
expressed speciﬁcally in developing inhibitory neurons of the dorsal
horn (Gross et al., 2002; Müller et al., 2002; Cheng et al., 2004; John et
al., 2005; Pillai et al., 2007). Bhlhb5 is preferentially, but not
exclusively expressed in inhibitory neurons (Liu et al., 2007). We
analyzed the expression of Neurod1/2/6 in dorsal horn neurons, which
previously was not assessed in detail (Fig. 5). In accordance with our
Affymetrix microarray analysis, Neurod1 is transiently expressed in
the maturing dorsal horn. Expression peaks around midgestation, and
only a small neuronal subpopulation expresses Neurod1 at E18.5 (Figs.
5A, B, F). Neurod2 and Neurod6 are expressed at E12.5 in dorsal horn
neurons, and transcripts can still be detected in a small neuronal
subpopulation at E18.5 (Figs. 5G, H, L and M, N, R). Expression of
Neurod1, Neurod2 and Neurod6 genes was signiﬁcantly down-
regulated in the dorsal horn of Ptf1a and Pax2 mutant mice at E13.5Fig. 7. Pax2, Neurod1/2/6 and Lhx1/5 control neuropeptide expression in dorsal inhibitory sp
dynorphin, galanin, NPY, nociceptin and enkephalin and the markers of inhibitory neurons
Lbx1Cre mutant mice at stage E18.5. (A1–4) Dynorphin expression was absent in the dorsal ho
mice. (B1–4) Galanin+ neurons were strongly reduced in Pax2−/− and Neurod1/2/6−/−, but were
was reduced in Pax2−/− mice and absent in Lhx1ﬂox Lhx1ﬂox/ﬂox;Lhx5−/−;Lbx1Cre mice, and was u
the dorsal horn of Pax2−/−mice, and unchanged in Lhx1ﬂox/ﬂox;Lhx5−/−;Lbx1Cre and Neurod1/2/6
Pax2−/− mice, but their number was not altered; the number of enkephalin+ dorsal neurons
mice. (F1–4) Pax2 expression was unchanged in the dorsal horn of Neurod1/2/6−/− mice, bu
sections were hybridized with a probe that recognizes transcribed sequences shared by the w
Pax2−/− mice were mislocated. (G1–4) Gad1 expression was lost in the dorsal spinal cord of P
Neurod1/2/6−/− mice. (A5–E5) Quantiﬁcation of the neuronal subtypes that express speciﬁc
control and mutant mice. Error bars represent the standard deviation. Scale bar: 100 μm.(Figs. 5C, E; I, K and O, Q). In contrast, the expression of Neurod1,
Neurod2 and Neurod6 genes was upregulated in Gsx1/2 mutant mice
(Figs. 5D, J, P). Co-expression of Neurod1/2/6 and Lhx1/5 or Tlx3 was
assessed by immunohistochemistry; Lhx1/5 or Tlx3 mark inhibitory
and excitatory neurons, respectively. This demonstrated that the
majority of Neurod1+ and Neurod2+ neurons of the dorsal horn co-
express Lhx1/5 at E14.5 (Figs. 6A, B). Neurons that co-express Neurod1
or Neurod2 and Tlx3 were only rarely observed (Figs. 6D, E). Since
speciﬁc anti-Neurod6 antibodies were not available, we used amutant
mouse strain in which Cre replaces Neurod6 coding sequences, and
analyzed Cre produced from the Neurod6Cre locus by anti-Cre
antibodies. The majority of Cre+ neurons of Neurod6Cre/+ mice co-
expressed Lhx1/5, and only few co-expressed Tlx3 (Figs. 6C, F). We
conclude that the Neurod1/2/6 factors are preferentially expressed in
inhibitory neurons.
To assess the effects of Pax2, Lhx1/5 and Neurod1/2/6 on
peptidergic differentiation, we analyzed the corresponding mutant
mouse strains for the expression of neuropeptides in the dorsal
horn at E18.5 (Fig. 7). Pax2 is known to control the initiation of
Gad1 expression and the GABAergic fate in the dorsal horn (Cheng
et al., 2004; see also Fig. 7G1,2). Dynorphin and galanin expression
were markedly downregulated in Pax2 mutant compared to control
mice (Figs. 7A1,2 and B1,2; see A5 and B5 for a quantiﬁcation). The
numbers of NPY+ and nociceptin+ neurons were severely reduced,
but the number of enkephalin+ neurons was unaffected (Figs.
7C1,2,5; D1,2,5 and E1,2,5). Remaining NPY+, enkephalin+ and
nociceptin+ neurons were not distributed correctly (Figs. 7C2, D2,
E2). The mutant Pax2 gene used in this study lacks exons 1 and 2,
but retains other exons of the Pax2 locus (Torres et al., 1995). We
used in situ hybridization and a probe that detects remaining exon
sequences, and observed that neurons that express mutant Pax2
transcripts were present but aberrantly distributed in the homo-
zygous mutant mice (Fig. 7F2 and supplemental Fig. 1). Weinal cord neurons. In situ hybridization with probes directed against the neuropeptides
Pax2 and Gad1 on sections of wild type, Pax2−/−, Neurod1/2/6−/− and Lhx1ﬂox/ﬂox;Lhx5−/−;
rn of Pax2−/− and Neurod1/2/6−/− mice, but was unchanged in Lhx1ﬂox/ﬂox;Lhx5−/−;Lbx1Cre
unchanged in the dorsal horn of Lhx1ﬂox/ﬂox;Lhx5−/−;Lbx1Cre mice. (C1–4), NPY expression
nchanged in Neurod1/2/6−/− mice. (D1–4) Nociceptin expression was severely reduced in
−/− mice. (E1–4) Enkephalin expressing cells were mislocated in the dorsal spinal cord of
was unchanged in Neurod1/2/6−/−mice, and downregulated in Lhx1ﬂox/ﬂox;Lhx5−/−;Lbx1Cre
t was reduced in the dorsal spinal cord of Lhx1ﬂox/ﬂox;Lhx5−/−;Lbx1Cre mice. Spinal cord
ild type and targeted Pax2 locus. Dorsal horn neurons detected with this Pax2 probe in
ax2 mutant mice and reduced in Lhx1ﬂox/ﬂox;Lhx5−/−;Lbx1Cre mice, but was unchanged in
neuropeptides. Neuropeptide+ cells were counted in one side of dorsal spinal cords of
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Fig. 8. Neurod1/2/6 cooperate to regulate the expression of dynorphin and galanin. In situ hybridization with probes directed against the neuropeptides dynorphin (A–H) and galanin
(I–P) on sections of control and Neurod single, double and triple mutant mice at E18.5. The numbers of dynorphin+ neurons were comparable in control,Neurod1 and Neurod6mutant
mice (A, B, D), but lowered in Neurod2mutants (C). The number of dynorphin+ neurons was reduced in Neurod1/2 and Neurod2/6 (E, G), but not in Neurod1/6 double mutant mice (F).
A complete loss of dynorphin expression was observed in the spinal cords of Neurod1/2/6 triple mutant mice (H). Galanin+ neurons are scattered over the dorsal horn and present in
comparable numbers in control (I) and Neurod1, Neurod6 and Neurod1/6 mutant mice (J, L, N). In Neurod2 mutant mice, galanin+ neurons are present in reduced numbers (K). The
reduction of galanin+ neurons is even more pronounced in Neurod1/2 and Neurod2/6 double mutant mice (M, O). In Neurod1/2/6 mutant mice, only few galanin+ neurons remain in
the medial part of the spinal cord (P). (Q, R) Quantiﬁcation of the neuronal subtypes that express dynorphin (Q) or galanin (R). Error bars represent the standard deviation. Scale bar:
100 μm.
390 D. Bröhl et al. / Developmental Biology 322 (2008) 381–393conclude that Pax2 is essential to control the expression of Gad1,
dynorphin and galanin. In addition, Pax2 is required for correct
NPY and nociceptin expression and appropriate migration of the
dorsal horn neurons.
Lhx1, Lhx5 and Pax2 are co-expressed in inhibitory neurons of the
developing dorsal spinal cord (Gross et al., 2002; Müller et al., 2002).
Previous analysis demonstrated that Lhx1/5 and Pax2 cross-regulate
each other (Pillai et al., 2007). Lhx1 and Lhx5 do not control the initial
speciﬁcation of the neuronal cell types in which they are expressed,
but are required tomaintain the expression of Pax2 and Gad1 (Pillai et
al., 2007; see also Fig. 7F1,4). We found that NPY is not expressed in the
dorsal horn of Lhx1/5 compound mutant mice (Fig. 7C4,5). Further-
more, dorsal enkephalin+ and Gad1+ neurons were reduced in
numbers in Lhx1/5 mutant mice, and remaining enkephalin+ or
Gad1+ neurons clustered medially in the deep dorsal horn (Figs. 7E4,5,
G4). The numbers of nociceptin+, dynorphin+ and galanin+ neurons
were unchanged (Figs. 7A4,5, B4,5, D4,5). Singlemutations in the Lhx1 or
Lhx5 gene did not impair the expression of neuropeptides (not
shown). Together, these data indicate that Lhx1 and Lhx5 cooperate to
control the expression of NPY.
Differentiation of peptidergic neurons in the dorsal spinal cord was
analyzed in Neurod1/2/6 compound mutant mice. The spinal cord
appeared normal in size, and we did not observe changes in Pax2 or
Gad1 expression in Neurod1/2/6 mutant mice (Figs. 7F3 and G3).
However, the number of dynorphin+ or galanin+ neurons was stronglyreduced in the dorsal spinal cord (Figs. 7A3,5 and B3,5). Smaller effects
on the numbers of dynorphin+ and galanin+ neurons were observed
in Neurod1/2 and Neurod2/6mutant mice, whereas the numbers were
unaffected in Neurod1/6 mutant mice (Fig. 8). Together, our data
demonstrate that Neurod genes act downstream of Pax2 to control the
expression of dynorphin and galanin in the dorsal horn (Figs. 5 and 7).
Expression of NPY, nociceptin and enkephalin was not signiﬁcantly
affected by mutations in the Neurod genes (Figs. 7C3, D3, E3; see C5, D5,
E5 for quantiﬁcation).
Discussion
Small neuronal subpopulations of the dorsal spinal cord express
different neuropeptides, which modulate sensory perception and
are particularly important for the sensation of pain (Marti et al.,
1987; Todd and Spike, 1993; Shi et al., 1999; Xu et al., 2000;
Przewlocki and Przewlocka, 2001; Wiesenfeld-Hallin et al., 2005;
Brumovsky et al., 2007). Despite their physiological importance, little
is known about the mechanisms that control peptidergic differentia-
tion. For instance, it is unclear if neuropeptide and neurotransmitter
expression are determined in a coordinate manner. Similarly, the
molecular mechanisms that control the peptidergic fate are unclear.
We demonstrate here that neuropeptides are expressed speciﬁcally in
the inhibitory and excitatory neuronal lineages in the dorsal horn. Our
further analysis demonstrated that distinct aspects of the inhibitory
391D. Bröhl et al. / Developmental Biology 322 (2008) 381–393neuronal differentiation program are controlled by the transcription
factors Pax2, Neurod1/2/6 and Lhx1/5. In particular, we show that
Neurod1/2/6 and Lhx1/5 control distinct peptidergic fates of inhibi-
tory neurons.
Genome wide expression analysis of dorsal horn neurons
According to the currentmodel, neuronal identity is determined by
the combinatorial action of speciﬁc transcription factors that are
either regulated by feedforward or by cross-repressive mechanisms
(Shirasaki and Pfaff, 2002; Baumgardt et al., 2007). Thus, neurons
express at early stages of their development a characteristic
transcription factor code that controls their subsequent differentiation
and suppresses other developmental programs. When late neuronal
markers are taken into account, it becomes evident that the early
transcription factor code often deﬁnes a functional class rather than a
single neuronal cell type (for examples see Tsuchida et al., 1994; Sapir
et al., 2004; Li et al., 2005; Chen et al., 2006; Luo et al., 2007). Thus,
dorsal horn neurons that share a particular transcription factor code
(Lbx1, Pax2 and Lhx1/5) mature to generate inhibitory neurons with
variable peptidergic fates.
We used global gene expression analysis to identify neuropeptides
expressed duringmaturation of the dorsal horn. This revealed thirteen
neuropeptides to be expressed in either inhibitory or excitatory
neurons (category A and B, respectively; Fig. 9B). Thus, despite the
heterogeneity of dorsal horn neurons, genome wide expression
analysis combined with the use of mouse mutants made it possibleFig. 9. Coordinatemechanisms control neurotransmitter and neuropeptide phenotypes.
(A) Postmitotic inhibitory and excitatory neurons are generated from dorsal progenitor
cells in the spinal cord (P). Inhibitory neurons require Ptf1a for development and
express category A neuropeptides and the transcription factors Pax2 and Lhx1/5.
Excitatory neurons require Gsx1/2 for development and express category B neuropep-
tides. (B) Category A or B neuropeptides were classiﬁed according to their differential
expression in the dorsal horn of Gsx1/2 and Ptf1a mutant mice. (C) Model of the
mechanisms that control neurotransmitter and neuropeptide phenotypes in inhibitory
neurons. Pax2 controls the expression of Gad1 and GABAergic differentiation. In
addition, Pax2 controls, apparently via the downstream transcription factors Neurod1/
2/6, the expression of the neuropeptides dynorphin and galanin. Lhx1/5 and Pax2
control the expression of each other in dorsal horn neurons. Lhx1/5 control in addition
the expression of the neuropeptides NPY and enkephalin independently of Pax2.to assign the expression of genes to a functional neuronal class.
Among the category A and B neuropeptides identiﬁed, only few were
previously found to be expressed preferentially in inhibitory or
excitatory neurons of the dorsal horn (Todd et al., 1992; Proudlock et
al., 1993; Rowan et al., 1993; Simmons et al., 1995; Todd et al., 2003;
Polgar et al., 2006; Schneider and Walker, 2007).
The expression of category A and B neuropeptides was regulated in
a complementary manner in Ptf1a and Gsx1/2 mutant mice that lack
inhibitory and excitatory neurons, respectively. Thus, the numbers of
neurons in the dorsal horn that express category A neuropeptides
were severely reduced in Ptf1a mutants, and increased in Gsx1/2
mutant mice. In contrast, the numbers of neurons that express
category B neuropeptides were increased in Ptf1a and severely
reduced in Gsx1/2 mutant mice. These data demonstrate that the
peptidergic fate of inhibitory neurons is independent of signals
provided by excitatory neurons, and vice versa, that the peptidergic
fate of excitatory neurons does not rely on signals from inhibitory
neurons. Cell autonomous mechanisms appear thus to play an
important role in the control of the peptidergic fate. Like spinal cord
inhibitory neurons, the GABAergic interneurons of the mouse
neocortex represent a highly heterogeneous population. The majority
of these interneurons arise from the medial ganglionic eminence,
migrate tangentially into the cortical plate, and they can be classiﬁed
according to their electrophysiological properties and morphological
criteria. Recent fate mapping experiments have demonstrated that
subtypes of cortical interneurons are generated in a temporal
sequence (Miyoshi et al., 2007). It remains to be elucidated if distinct
peptidergic neuron types of the spinal cord are generated at distinct
time points. The differences in the time course of the appearance of
transcription factors like Neurod1 and Neurod6 could be in accor-
dance with such a mechanism. In the cortex, many of the distinct
interneuron types reside preferentially in particular cortical layers
(DeFelipe, 1993; Kawaguchi and Kondo, 2002; Markram et al., 2004).
In the spinal cord at E18, mainly category B neuropeptides (CCK, TAC1,
GRP and PACAP) expressing neurons are concentrated in speciﬁc
layers. This correlates with the layer-speciﬁc expression of transcrip-
tion factors present in the excitatory lineage (Chen et al., 2001; Gross
et al., 2002; Müller et al., 2002; Qian et al., 2002; Ding et al., 2004). In
contrast, most category A neuropeptides are expressed by neurons
scattered over the entire dorsal horn at E18 (NPY, nociceptin and
enkephalin). Exceptions are dynorphin, that is preferentially
expressed by neurons of the upper dorsal horn, and galanin, which
appears to be expressed by two distinct neuronal populations, one
large population that locates to upper layers of the dorsal horn and
that depends on Ptf1a and Neurod1/2/6, and by a second small
population that resides in deep layers and is independent of Ptf1a and
Neurod1/2/6.
Coordinate mechanisms control neurotransmitter and neuropeptide
phenotypes
We identiﬁed several components of a transcriptional network
that controls peptidergic fate of inhibitory neurons in the dorsal horn.
Genetically, the components of the network can be assembled in a
hierarchy, in which Ptf1a acts as an upstream regulator. Pax2 operates
downstream, determines the inhibitory (GABAergic) fate by control-
ling Gad1 and, in addition, the expression of galanin and dynorphin,
apparently via Neurod1/2/6. Ptf1a also controls Lhx1/5, which are
essential for NPY expression (see Fig. 9 for a summary). Such a
hierarchical model cannot account for all aspects of the differentiation
of inhibitory neurons, since the transcription factors important for
differentiation also cross-regulate each other. For instance, Lhx1/5 are
essential tomaintain correct Pax2 expression, but not for the initiation
of Pax2 (Pillai et al., 2007). Similarly, Lhx1/5 expression is reduced in
Pax2 mutant mice. Thus, the transcription factors involved in
differentiation of inhibitory neurons function not only in a linear
392 D. Bröhl et al. / Developmental Biology 322 (2008) 381–393cascade, but form a network in which they control the expression of
each other and the execution of the differentiation program (Fig. 9).
Transcriptional networks that cooperate to control the expression of
network members and the differentiation program were previously
suggested to operate during differentiation of other cell types, for
instance sympathetic neurons (Goridis and Rohrer, 2002). The cross-
regulation of Lhx1/5 and Pax2 in dorsal spinal cord neuronsmight also
account for the mild effect of the Pax2 mutation on NPY expression,
which is less pronounced than the one we observe in Lhx1/5 mutant
mice. However, cross-regulation cannot account for the effects
observed on galanin and dynorphin expression; expression of galanin
and dynorphin is essentially abrogated in Pax2 mutants but
unchanged in Lhx1/5 mutant mice. Thus, Pax2 appears to function
independently of Lhx1/5 in the control of galanin and dynorphin
expression.
Pax2 is essential for the correct expression of Neurod1/2/6 in
inhibitory neurons, and Pax2 and Neurod1/2/6 are broadly expressed
in the inhibitory lineage at E12.5. However, Neurod1/2/6 are
expressed only in a small fraction of neurons at E18.5, a time point
at which Pax2 is still expressed broadly. Thus, initiation and
maintenance of Neurod1/2/6 are controlled by distinct mechanisms,
and silencing of Neurod1/2/6 in the majority of dorsal inhibitory
neurons might ensure that the (direct or indirect) target genes
dynorphin and galanin are only produced by small subpopulations.
We also observed that Lhx1/5 are broadly expressed in newborn
inhibitory neurons at E12.5, similar to the expression of the (direct or
indirect) target gene NPY (D.B., unpublished observations). Whereas
Lhx1/5 expression is maintained in many inhibitory neurons at E18.5,
NPY transcripts are observable only in a fraction. Further work is
required to deﬁne the mechanism that maintains NPY expression in a
subpopulation of Lhx1/5+ inhibitory neurons.
While this manuscript was under review, a study on Tlx1/3
function in peptidergic speciﬁcation of excitatory neurons in the
dorsal spinal cord appeared in press (Xu et al., 2008). In accordance
with our ﬁndings, this paper reports that CCK, TAC1, TAC2 and
somatostatin are preferentially expressed in excitatory neurons,
whereas dynorphin and enkephalin are present in inhibitory neurons.
Furthermore, the study demonstrates that peptidergic and glutama-
tergic differentiation are controlled in a coordinated manner in the
dorsal spinal cord. Thus, peptidergic and neurotransmitter pheno-
types are coordinately determined in the excitatory lineage (Xu et al.,
2008) and in inhibitory neurons (this study).
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